David Hanley

David Hanley

Chief Tech/Sci/R&D Officer at NUVATION BIO INC.

Net worth: 114 720 $ as of 2026-05-30

56 year
Health Technology
Consumer Services

Profile

David C.
Hanley
is Chief Technical Operations Officer at Nuvation Bio, Inc. since 2021.
Formerly, Senior Director-Global Pharmaceutical Development at The Medicines Co. from 2011 to 2014, VP-Pharmaceutical Sciences & Technical Operations at Radius Health, Inc. from 2014 to 2018, and Senior VP & Head-Global Pharmaceutical Development at BioXcel Therapeutics, Inc. from 2018 to 2021.
Education includes a doctorate from the University of Utah and an undergraduate degree from Virginia Commonwealth University.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2026-02-26 24,000 ( 0.01% ) 114 720 $ 2026-05-30

David Hanley active positions

CompaniesPositionStart
NUVATION BIO INC. Chief Tech/Sci/R&D Officer 2021-05-31

Former positions of David Hanley

CompaniesPositionEnd
BIOXCEL THERAPEUTICS, INC. Corporate Officer/Principal 2021-04-30
RADIUS HEALTH, INC. Corporate Officer/Principal 2018-07-31
THE MEDICINES COMPANY Corporate Officer/Principal 2014-07-31
See the detail of David Hanley's experience

Training of David Hanley

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

37

1st degree connections

6

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies6

Health Technology

Health Technology

Consumer Services

Consumer Services

Health Technology

Health Technology